Search

Your search keyword '"Williams, Louis"' showing total 1,078 results
Start Over Author "Williams, Louis"
1,078 results on '"Williams, Louis"'

2. Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Author

Dima, Danai, Abdallah, Al-Ola, Davis, James A., Awada, Hussein, Goel, Utkarsh, Rashid, Aliya, DeJarnette, Shaun, Anwer, Faiz, Shune, Leyla, Raza, Shahzad, Mahmoudjafari, Zahra, Williams, Louis, Faiman, Beth, McGuirk, Joseph P., Sauter, Craig S., Ahmed, Nausheen, Khouri, Jack, and Hashmi, Hamza

Published
2024
Full Text
View/download PDF

4. A Correlation Study of College's Retention Policies and Immigrant Student Success

Author

Williams Louis, Chimene

Abstract

The value of a college degree has grown significantly for both society and individuals over the last decades. Research shows a large earning gap between individuals with a high school diploma or GED and higher education levels. Many individuals start their postsecondary journey with a public institution. Community colleges must design academic curricula and strategies to produce planned and comprehensible paths, with built-in improvement monitoring and feedback along the way. This quantitative correlational study aimed to discover the relationship between retention policies and immigrant students 'success in attending community colleges. Families rely on community colleges to create comprehensive policies and provide resources beneficial to their children's school and workforce success. Although federal policies have long posed barriers for immigrant students' educational attainment, they strive to further their education, hoping that things will change in the future. Immigrant students attend community colleges with temporary legal permission, legal permanent residency, or by becoming citizens. Most immigrant students do not gain an easy path to live in the United States legally. Still, studies demonstrate that attending a higher education institution is the best way to succeed. This study set out to examine whether a relationship exists between student success and GPA, between student success and gender, and if a relationship exists between retention and academic progress concerning immigrant students. If there is a relationship, this will be another tool to identify immigrant students who needed extra support from the community colleges and the faculty before they dropped out of college. Out of the 700 students, there were 435 females and 265 males. The result demonstrated that 435 persisted and graduated in 2019, and 265 continued despite their low GPA. It appeared that Bourdieu's theory could be beneficial to higher education officials in recognizing students who may need further support. The study results will enable researchers to investigate different retention strategies that community colleges can use to help immigrant students. Furthermore, this study has practical implications for higher education institution personnel, including faculty, admissions personnel, student service personnel, and community support. [The dissertation citations contained here are published with the permission of ProQuest LLC. Further reproduction is prohibited without permission. Copies of dissertations may be obtained by Telephone (800) 1-800-521-0600. Web page: http://www.proquest.com/en-US/products/dissertations/individuals.shtml.]

Published
2022

7. Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience

Author

Khouri, Jack, Dima, Danai, Li, Hong, Hansen, Doris, Sidana, Surbhi, Shune, Leyla, Anwer, Faiz, Sborov, Douglas, Wagner, Charlotte, Kocoglu, Mehmet H., Atrash, Shebli, Voorhees, Peter, Peres, Lauren, Hovanky, Vanna, Simmons, Gary, Williams, Louis, Raza, Shahzad, Afrough, Aimaz, Anderson, Larry D., Jr, Ferreri, Christopher, Hashmi, Hamza, Davis, James, McGuirk, Joseph, Goldsmith, Scott, Borogovac, Azra, Lin, Yi, Midha, Shonali, Nadeem, Omar, Locke, Frederick L., Baz, Rachid, Hamilton, Betty, Alsina, Melissa, Sauter, Craig, Patel, Krina, and Kaur, Gurbakhash

Published
2024
Full Text
View/download PDF

8. Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma.

Author

Lytvynova, Olga, Jwayyed, Jenna, Pastel, Daniel, Prasad, Rohan, Khouri, Jack, Williams, Louis, Mazzoni, Sandra, Raza, Shahzad, and Anwer, Faiz

Subjects
MULTIPLE myeloma, ADVERSE health care events, HEMATOLOGIC malignancies, OVERALL survival, RECOMBINANT antibodies
Abstract

Multiple myeloma (MM) is a hematological malignancy and poses significant therapeutic challenges. This review synthesizes evidence from pivotal clinical trials to guide induction treatment for transplant-eligible (TE), newly diagnosed MM (NDMM) patients. Emphasizing the evolution from three-drug to four-drug induction therapies, we highlight the integration of monoclonal antibodies, particularly CD38 recombinant monoclonal antibody agents, into treatment regimens. This analysis includes a comprehensive literature review of research from major databases and conferences conducted between 2010 and 2023, culminating in the detailed evaluation of 47 studies. The findings underscore the superiority of quadruple regimens in TE NDMM, notably those incorporating daratumumab, in achieving superior responses including progression-free survival (PFS), minimal residual disease (MRD) negativity, objective response rate (ORR), and overall survival (OS) when compared to triple-drug regimens. As treatment regimens evolve with additional agents, the improved outcomes with treatment-related adverse events should be carefully balanced. This review advocates for a paradigm shift towards quadruple induction therapies for TE NDMM, offers a detailed insight into the current landscape of MM treatment, and reinforces a new standard of care. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Chromothripsis as a pathogenic driver of multiple myeloma

Author

Maura, Francesco, Boyle, Eileen M., Rustad, Even H., Ashby, Cody, Kaminetzky, David, Bruno, Benedetto, Braunstein, Marc, Bauer, Michael, Blaney, Patrick, Wang, Yubao, Ghamlouch, Hussein, Williams, Louis, Stoeckle, James, Davies, Faith E., Walker, Brian A., Maclachlan, Kylee, Diamond, Ben, Landgren, Ola, and Morgan, Gareth J.

Published
2022
Full Text
View/download PDF

12. Efficacy of low-dose direct oral anticoagulants (DOACs) for venous thromboembolism prophylaxis in newly diagnosed multiple myeloma.

Author

Basali, Diana, primary, Zureigat, Hadil, additional, Nurse, Daniel Paul, additional, Elmaleh, Hassan, additional, Batah, Heya, additional, Adcock, Bridget, additional, Wei, Wei, additional, Dima, Danai, additional, Valent, Jason Neil, additional, Anwer, Faiz, additional, Samaras, Christy Joy, additional, Khouri, Jack, additional, Williams, Louis, additional, Raza, Shahzad, additional, van Heeckeren, Willem Jan, additional, and Mazzoni, Sandra Ann, additional

Published
2024
Full Text
View/download PDF

13. Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

Author

Boyle, Eileen M., Williams, Louis, Blaney, Patrick, Ashby, Cody, Bauer, Michael, Walker, Brian A., Ghamlouch, Hussein, Choi, Jinyoung, Perrial, Emeline, Wang, Yubao, Caro, Jessica, Stoeckle, James H., Arbini, Arnaldo, Kaminetzky, David, Braunstein, Marc, Bruno, Benedetto, Razzo, Beatrice, Diamond, Benjamin, Maclachlan, Kylee, Maura, Francesco, Landgren, Ola, Litke, Rachel, Fegan, Christopher D., Keats, Johnathan, Auclair, Daniel, Davies, Faith E., and Morgan, Gareth J.

Published
2022
Full Text
View/download PDF

16. The relationship between the creation and perception of art

Author

Williams, Louis

Subjects
153.7
Abstract

It is suggested that similar cognitive processes are involved with both the creation and perception of art. However, a lack of research examines this relationship, whether this is just from the perspective of the artist, or in relation to the artist and perceiver of the final product. To do so, we examined the experience of artists and non‐artists investigating initial stages of art‐making by examining relationships between aesthetic and drawing preferences of geometric stimuli (Experiments 1 & 2). To further understand this experience, we allowed artists and non‐artists to be involved in actual drawing activity (stippling and stroking) whilst making drawing preferences. We also examined how being involved in drawing influenced aesthetic preferences (Experiment 3), this led to conducting studies considering perceivers (artists/non‐artists) of artworks. Here, we investigated how congruent actions (simultaneously produced or learnt during pre‐training) with the artists behind the artwork influenced aesthetic responses (Experiments 4 & 5). Examination of gaze behaviour throughout these studies provides further insight into the aesthetic experience by revealing the processes behind formations of judgements. Overall, we conclude that there are similarities between experiences (gaze and judgments) involved in the creation and perception of art. We find similarities between aesthetic and drawing preferences and find gaze to be impacted in a similar manner when observing images in comparison to making a drawing choice. We do not provide support that these drawing choices are influenced by being involved with drawing but do show that the more experience a perceiver receives with these actions of the artist the more their aesthetic judgements are influenced by these, supporting the relationship between artist and perceiver depicted in the mirror model of art. We provide a foundation for future research to empirically analyse connections between the creation and perception of art and the relationships between the artist and perceiver.

Published
2017

18. Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.

Author

Dima, Danai, Hughes, Michael, Orland, Mark, Ullah, Fauzia, Goel, Utkarsh, Anwer, Faiz, Raza, Shahzad, Mazzoni, Sandra, Bhutani, Divaya, Williams, Louis, Lentzsch, Suzanne, Samaras, Christy, Valent, Jason, Chakraborty, Rajshekhar, and Khouri, Jack

Subjects
OVERALL survival, FAILURE (Psychology), SALVAGE therapy, TREATMENT failure, CARDIAC patients
Abstract

Background: Daratumumab's incorporation in the upfront treatment of light chain (AL) amyloidosis has led to daratumumab (dara) refractoriness early in disease course. Patients who experience relapse or have suboptimal response to dara-based-therapy, have limited options. Objective: This study aimed to evaluate the outcomes of venetoclax-based therapy in t(11;14) positive AL patients who previously failed dara. Methods: Thirty-one patients with AL were included in this bi-institutional retrospective analysis. Results: Dara failure was due to inadequate response in 20 (65%) patients, haematologic relapse in 7 (22%), and both haematologic plus organ relapse in 4 (13%). Overall haematologic response rate to venetoclax-based therapy was 97%, with ≥ VGPR being 91%. Of the 19 evaluable patients with cardiac involvement, 14 (74%) achieved organ response. Of the 13 evaluable patients with renal involvement, 6 (46%) achieved organ response. With a median follow-up of 22 months, median time-to-next-treatment (TTNT) and overall survival (OS) were not reached. The 12- and 24-month TTNT rates were 74% and 56%, respectively. At data-cut-off, four patients had died, all from AL-related organ complications. The 12- and 24-month OS rates were 89% and 85%, respectively. Grade ≥3 adverse events occurred in 26% of patients, with 6% due to infections. Conclusion: These findings are encouraging for the use of venetoclax as salvage therapy post-dara failure. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin's Lymphoma (NHL) and Multiple Myeloma (MM) Treated with CAR T-Cell Therapies.

Author

Mian, Agrima, primary, Dima, Danai, additional, Hamilton, Betty K., additional, Winter, Allison, additional, Khouri, Jack, additional, Williams, Louis, additional, Raza, Shahzad, additional, Jagadeesh, Deepa, additional, Gerds, Aaron T., additional, Dean, Robert M., additional, Sobecks, Ronald M., additional, Kalaycio, Matt E., additional, Brunstein, Claudio G., additional, Sauter, Craig S, additional, Anwer, Faiz, additional, Hill, Brian T., additional, and Caimi, Paolo, additional

Published
2024
Full Text
View/download PDF

24. Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia

Author

Awada, Hassan, Nagata, Yasunobu, Goyal, Abhinav, Asad, Mohammad F., Patel, Bhumika, Hirsch, Cassandra M., Kuzmanovic, Teodora, Guan, Yihong, Przychodzen, Bartlomiej P., Aly, Mai, Adema, Vera, Shen, Wenyi, Williams, Louis, Nazha, Aziz, Abazeed, Mohamed E., Sekeres, Mikkael A., Radivoyevitch, Tomas, Haferlach, Torsten, Jha, Babal K., Visconte, Valeria, and Maciejewski, Jaroslaw P.

Published
2019
Full Text
View/download PDF

25. Efficacy and safety of idecabtagene vicleucel in patients with relapsed–refractory multiple myeloma not meeting the KarMMa‐1 trial eligibility criteria: A real‐world multicentre study

Author

Dima, Danai, primary, Rashid, Aliya, additional, Davis, James A., additional, Shune, Leyla, additional, Abdallah, Al‐Ola, additional, Li, Hong, additional, DeJarnette, Shaun, additional, Khouri, Jack, additional, Williams, Louis, additional, Hashmi, Hamza, additional, Raza, Shahzad, additional, McGuirk, Joseph, additional, Anwer, Faiz, additional, and Ahmed, Nausheen, additional

Published
2024
Full Text
View/download PDF

26. Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.

Author

Dima, Danai, Goel, Utkarsh, Sannareddy, Aishwarya, Ibeh, Nnaemeka, Ullah, Fauzia, Afrough, Aimaz, Mazzoni, Sandra, Mehdi, Ali, Rudoni, Joslyn, Raza, Shahzad, De Simone, Nicole, Williams, Louis, Khan, Adeel, Rashid, Aliya, Rice, Mikhaila, Ricci, Kristin, Samaras, Christy, Valent, Jason, Anderson, Larry D., and Anwer, Faiz

Subjects
PLASMA exchange (Therapeutics), TREATMENT effectiveness, MULTIPLE myeloma, IMMUNOGLOBULIN light chains, KIDNEY diseases
Abstract

Current treatment guidelines of myeloma cast nephropathy (MCN) recommend the institution of plasma cell‐directed therapy and consideration of therapeutic plasma exchange (TPE), with the goal of rapid reduction of the serum free light chain (sFLC). However, the role of TPE continues to remain a subject of debate. The goal of this retrospective bi‐institutional study was to evaluate the clinical outcomes of TPE in combination with systemic therapy. Eighty patients were included in this analysis, of whom 72.5% had ≥50% drop in their initial involved sFLC. At 3 months from TPE initiation, the overall hematologic response rate (ORR) was 67.5% with a very good partial response or better (≥VGPR) rate of 40%. At 6 months, ORR was 57.5%, with ≥VGPR rate of 49%. The renal response rate at 3 and 6 months was 47.5% and 43.75%, respectively; the overall renal response rate was 48.75%. On multivariable analysis, every one unit increase in baseline creatinine (odds ratio [OR] 0.76, p = 0.006), and achievement of ≥VGPR (OR 21.7 p < 0.0001) were significantly associated with renal response. Also, a ≥50% drop in sFLC was favorably associated with renal response (OR 3.39, p = 0.09). With a median follow‐up of 36.4 months, the median overall survival (OS) was 11 months. On multivariable analysis, achievement of renal response (hazard ratio [HR] 0.3, p < 0.0001) and newly diagnosed disease (NDMM; HR 0.43, p = 0.0055) were associated with improved OS. Among NDMM patients, those treated with daratumumab‐based regimens had a trend for better OS (p = 0.15), compared to other regimens, but the difference was not significant. At the end of follow‐up, an estimated 40.4% of patients who were on dialysis were able to become dialysis independent. In conclusion, our study highlights the poor survival of patients with MCN. Achievement of early renal response is crucial for prolonged OS, with daratumumab‐based therapies showing promise. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. People are people: A comparative analysis of risk attitudes across Europe.

Author

Brooks, Chris and Williams, Louis

Subjects
FINANCIAL risk, RISK assessment, INDIVIDUAL investors, DISEASE risk factors, INVESTORS, ATTITUDE (Psychology), DISTRIBUTION planning
Abstract

In this paper, we conduct a detailed examination of the determinants of attitudes to financial risk among retail investors in six European countries (Belgium, France, Germany, Italy, Spain and the United Kingdom). We find that respondents from the United Kingdom and Belgium are the most risk tolerant while those from Spain are the least. We observe remarkable similarities in the distributions of risk tolerance across countries despite cultural differences and considerable variations in the extent to which risky investing is undertaken as a routine part of financial planning. We further show that country effects in the cross‐sectional variation of attitude to risk scores are swamped by the impacts of gender, salary and wealth, while financial knowledge and prior investment experience are much more important still. Our results have implications for regulators and those who wish to encourage European investors to consider going beyond bank savings and guaranteed products to more prevalent stock market investing in an era of negative real interest rates. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, primary, Stoeckle, James H., primary, Wang, Yubao, primary, Ghamlouch, Hussein, primary, Gagler, Dylan, primary, Braunstein, Marc, primary, Williams, Louis, primary, Tenenbaum, Avital, primary, Siegel, Ariel, primary, Chen, Xiaoyi, primary, Varma, Gaurav, primary, Avigan, Jason, primary, Li, Alexander, primary, Jinsi, Monica, primary, Kaminetzsky, David, primary, Arbini, Arnaldo, primary, Montes, Lydia, primary, Corre, Jill, primary, Rustad, Even H., primary, Landgren, Ola, primary, Maura, Francesco, primary, Walker, Brian A., primary, Bauer, Michael, primary, Bruno, Benedetto, primary, Tsirigos, Aristotelis, primary, Davies, Faith E., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, primary, Stoeckle, James H., primary, Wang, Yubao, primary, Ghamlouch, Hussein, primary, Gagler, Dylan, primary, Braunstein, Marc, primary, Williams, Louis, primary, Tenenbaum, Avital, primary, Siegel, Ariel, primary, Chen, Xiaoyi, primary, Varma, Gaurav, primary, Avigan, Jason, primary, Li, Alexander, primary, Jinsi, Monica, primary, Kaminetzsky, David, primary, Arbini, Arnaldo, primary, Montes, Lydia, primary, Corre, Jill, primary, Rustad, Even H., primary, Landgren, Ola, primary, Maura, Francesco, primary, Walker, Brian A., primary, Bauer, Michael, primary, Bruno, Benedetto, primary, Tsirigos, Aristotelis, primary, Davies, Faith E., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, primary, Stoeckle, James H., primary, Wang, Yubao, primary, Ghamlouch, Hussein, primary, Gagler, Dylan, primary, Braunstein, Marc, primary, Williams, Louis, primary, Tenenbaum, Avital, primary, Siegel, Ariel, primary, Chen, Xiaoyi, primary, Varma, Gaurav, primary, Avigan, Jason, primary, Li, Alexander, primary, Jinsi, Monica, primary, Kaminetzsky, David, primary, Arbini, Arnaldo, primary, Montes, Lydia, primary, Corre, Jill, primary, Rustad, Even H., primary, Landgren, Ola, primary, Maura, Francesco, primary, Walker, Brian A., primary, Bauer, Michael, primary, Bruno, Benedetto, primary, Tsirigos, Aristotelis, primary, Davies, Faith E., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

32. Data from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, primary, Stoeckle, James H., primary, Wang, Yubao, primary, Ghamlouch, Hussein, primary, Gagler, Dylan, primary, Braunstein, Marc, primary, Williams, Louis, primary, Tenenbaum, Avital, primary, Siegel, Ariel, primary, Chen, Xiaoyi, primary, Varma, Gaurav, primary, Avigan, Jason, primary, Li, Alexander, primary, Jinsi, Monica, primary, Kaminetzsky, David, primary, Arbini, Arnaldo, primary, Montes, Lydia, primary, Corre, Jill, primary, Rustad, Even H., primary, Landgren, Ola, primary, Maura, Francesco, primary, Walker, Brian A., primary, Bauer, Michael, primary, Bruno, Benedetto, primary, Tsirigos, Aristotelis, primary, Davies, Faith E., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Methods S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, primary, Stoeckle, James H., primary, Wang, Yubao, primary, Ghamlouch, Hussein, primary, Gagler, Dylan, primary, Braunstein, Marc, primary, Williams, Louis, primary, Tenenbaum, Avital, primary, Siegel, Ariel, primary, Chen, Xiaoyi, primary, Varma, Gaurav, primary, Avigan, Jason, primary, Li, Alexander, primary, Jinsi, Monica, primary, Kaminetzsky, David, primary, Arbini, Arnaldo, primary, Montes, Lydia, primary, Corre, Jill, primary, Rustad, Even H., primary, Landgren, Ola, primary, Maura, Francesco, primary, Walker, Brian A., primary, Bauer, Michael, primary, Bruno, Benedetto, primary, Tsirigos, Aristotelis, primary, Davies, Faith E., primary, and Morgan, Gareth J., primary

Published
2023
Full Text
View/download PDF

34. P-256 Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA

Author

Faiman, Beth, primary, Dima, Danai, additional, Duco, Marissa, additional, Rice, Mikhaila, additional, Rudoni, Joslyn, additional, Anwer, Faiz, additional, Khouri, Jack, additional, Mazzoni, Sandra, additional, Raza, Shahzad, additional, Samaras, Christy, additional, Williams, Louis, additional, and Valent, Jason, additional

Published
2023
Full Text
View/download PDF

35. P-465 Global disparities in multiple myeloma: examining adverse events and drug toxicity trends

Author

Jaberi-Douraki, Majid, primary, Xu, Xuan, additional, Ramachandran, Remya Ampadi, additional, Faiman, Beth, additional, Anwer, Faiz, additional, Samaras, Christy, additional, Riviere, Jim, additional, Gedara, Nuwan Indika Millagaha, additional, Golmohammadi, Mobina, additional, Shaikh, Hira, additional, Shune, Leyla, additional, Masood, Ashiq, additional, Mazzoni, Sandra, additional, Williams, Louis, additional, Zhao, Jianjun, additional, Valent, Jason, additional, Dima, Danai, additional, Abbas, Ata, additional, Cossor, Furha, additional, Khouri, Jack, additional, and Raza, Shahzad, additional

Published
2023
Full Text
View/download PDF

36. Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

Author

Boyle, Eileen M., primary, Blaney, Patrick, additional, Stoeckle, James H., additional, Wang, Yubao, additional, Ghamlouch, Hussein, additional, Gagler, Dylan, additional, Braunstein, Marc, additional, Williams, Louis, additional, Tenenbaum, Avital, additional, Siegel, Ariel, additional, Chen, Xiaoyi, additional, Varma, Gaurav, additional, Avigan, Jason, additional, Li, Alexander, additional, Jinsi, Monica, additional, Kaminetzsky, David, additional, Arbini, Arnaldo, additional, Montes, Lydia, additional, Corre, Jill, additional, Rustad, Even H., additional, Landgren, Ola, additional, Maura, Francesco, additional, Walker, Brian A., additional, Bauer, Michael, additional, Bruno, Benedetto, additional, Tsirigos, Aristotelis, additional, Davies, Faith E., additional, and Morgan, Gareth J., additional

Published
2023
Full Text
View/download PDF

42. People are people: A comparative analysis of risk attitudes across Europe

Author

Brooks, Chris and Williams, Louis

Abstract

In this paper, we conduct a detailed examination of the determinants of atti- tudes to financial risk among retail investors in six European countries (Belgium, France, Germany, Italy, Spain and the United Kingdom). We find that respondents from the United Kingdom and Belgium are the most risk tol- erant while those from Spain are the least. We observe remarkable similarities in the distributions of risk tolerance across countries despite cultural differ- ences and considerable variations in the extent to which risky investing is undertaken as a routine part of financial planning. We further show that coun- try effects in the cross-sectional variation of attitude to risk scores are swamped by the impacts of gender, salary and wealth, while financial knowledge and prior investment experience are much more important still. Our results have implications for regulators and those who wish to encourage European inves- tors to consider going beyond bank savings and guaranteed products to more prevalent stock market investing in an era of negative real interest rates.

Published
2023
Full Text
View/download PDF

43. Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

Author

Dima, Danai, primary, Ullah, Fauzia, additional, Mazzoni, Sandra, additional, Williams, Louis, additional, Faiman, Beth, additional, Kurkowski, Austin, additional, Chaulagain, Chakra, additional, Raza, Shahzad, additional, Samaras, Christy, additional, Valent, Jason, additional, Khouri, Jack, additional, and Anwer, Faiz, additional

Published
2023
Full Text
View/download PDF

45. Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for Multiple Myeloma

Author

Awada, Hussein, primary, Hajj Ali, Adel, additional, Ali, Muhammad Faizan, additional, Sauter, Craig, additional, Hamilton, Betty, additional, Kalaycio, Matt, additional, Sobecks, Ronald, additional, Jagadeesh, Deepa, additional, Dean, Robert, additional, Winter, Allison, additional, Pohlman, Brad, additional, Williams, Louis, additional, Anwer, Faiz, additional, and Khouri, Jack, additional

Published
2023
Full Text
View/download PDF

47. Evaluation of Major Adverse Cardiac Events (MACE) and Arrhythmias in Patients with Large B-Cell Lymphoma Undergoing Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Utility of Baseline Cardiac Biomarkers

Author

Shah, Haikoo, primary, O’Conke, Danielle, additional, Zhao, Ran, additional, Jalota, Akansha, additional, Patel, Manishkumar, additional, Winter, Allison M., additional, Williams, Louis, additional, Khouri, Jack, additional, Jagadeesh, Deepa, additional, Anwer, Faiz, additional, Dean, Robert M., additional, Hamilton, Betty K., additional, Sobecks, Ronald M., additional, Pohlman, Brad, additional, Caimi, Paolo F., additional, Sauter, Craig S, additional, Gupta, Neetu, additional, and Hill, Brian T., additional

Published
2023
Full Text
View/download PDF

48. The Characteristics of Multiple Myeloma Patients Referred for CAR T-Cell Therapy

Author

Awada, Hussein, primary, Ali, Adel Hajj, additional, Sheu, Michael, additional, Patel, Meera, additional, Faiman, Beth, additional, Scott, Cynthia, additional, Mathur, Saveta, additional, Hamilton, Kimberly, additional, Samaras, Christy, additional, Mazzoni, Sandra, additional, Raza, Shahzad, additional, van Heeckeren, Willem, additional, Williams, Louis, additional, Valent, Jason, additional, Khouri, Jack, additional, and Anwer, Faiz, additional

Published
2023
Full Text
View/download PDF

49. Incidence of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant

Author

Awada, Hussein, primary, Ali, Adel Hajj, additional, Faiman, Beth, additional, Scott, Cynthia, additional, Mathur, Saveta, additional, Hamilton, Kimberly, additional, Samaras, Christy, additional, Mazzoni, Sandra, additional, Raza, Shahzad, additional, van Heeckeren, Willem, additional, Williams, Louis, additional, Valent, Jason, additional, Khouri, Jack, additional, and Anwer, Faiz, additional

Published
2023
Full Text
View/download PDF

50. Factors That Predict Early Relapse Post Autologous Hematopoietic Cell Transplant in Multiple Myeloma Patients

Author

Awada, Hussein, primary, Ali, Adel Hajj, additional, Faiman, Beth, additional, Scott, Cynthia, additional, Mathur, Saveta, additional, Hamilton, Kimberly, additional, Samaras, Christy, additional, Mazzoni, Sandra, additional, Raza, Shahzad, additional, van Heeckeren, Willem, additional, Williams, Louis, additional, Valent, Jason, additional, Khouri, Jack, additional, and Anwer, Faiz, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results